These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35591891)

  • 21. Perceptions of family, community and religious leaders and acceptability for minimal invasive tissue sampling to identify the cause of death in under-five deaths and stillbirths in North India: a qualitative study.
    Das MK; Arora NK; Kaur G; Malik P; Kumari M; Joshi S; Rasaily R; Chellani H; Gaikwad H; Debata P; Meena KR
    Reprod Health; 2021 Aug; 18(1):168. PubMed ID: 34348749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile and treatment outcomes among young patients with tuberculosis aged 15-24 years in Faridabad district of Haryana, India.
    Kamble BD; Malhotra S
    BMJ Open; 2022 Sep; 12(9):e060363. PubMed ID: 36171030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Need for operational simplicity and timely disbursal of benefits-a qualitative exploration of the implementation of a direct benefit transfer scheme for persons with tuberculosis in India.
    Mohan M; Thangaraj JWV; Pandey S; Sri Lakshmi Priya G; Arunachalam S; Sharma R; Shewade HD; Aishwarya B; Afeeq K; Khatoon A; Gokulvijay B; Sireesha G; Chandra K; Nandhakumar S; Samuel P; Nanditha Viswanathan C; Shanmugasundaram D; Rao R; Murhekar MV; Jeyashree K
    Infect Dis Poverty; 2024 May; 13(1):36. PubMed ID: 38783334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
    Mando TC; Sandy C; Chadambuka A; Gombe NT; Juru TP; Shambira G; Umeokonkwo CD; Tshimanga M
    PLoS One; 2023; 18(11):e0293867. PubMed ID: 37939099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial loss to follow up of tuberculosis patients in South Africa: perspectives of program managers.
    Mwansa-Kambafwile JRM; Jewett S; Chasela C; Ismail N; Menezes C
    BMC Public Health; 2020 May; 20(1):622. PubMed ID: 32375743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    Kawatsu L; Uchimura K; Ohkado A; Kato S
    PLoS One; 2018; 13(6):e0198075. PubMed ID: 29906287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss to follow up after pregnancy among mothers enrolled on the option B+ program in Uganda.
    Kiirya Y; Musoke P; Adobea Odei Obeng-Amoako G; Kalyango J
    Public Health Pract (Oxf); 2021 Nov; 2():100085. PubMed ID: 36101573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India.
    Thomas BE; Suresh C; Lavanya J; Lindsley MM; Galivanche AT; Sellappan S; Ovung S; Aravind A; Lincy S; Raja AL; Kokila S; Javeed B; Arumugam S; Mayer KH; Swaminathan S; Subbaraman R
    BMJ Glob Health; 2020; 5(2):e001974. PubMed ID: 32181000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "I lost my faith and stopped taking the medicines" - need for an intervention model based on health belief constructs for improving adherence to tuberculosis treatment.
    Solanki N; Sharma P; Rupani MP; Goswami B
    J Family Med Prim Care; 2022 Jun; 11(6):3006-3012. PubMed ID: 36119340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediagnostic loss to follow-up in an active case finding tuberculosis programme: a mixed-methods study from rural Bihar, India.
    Garg T; Gupta V; Sen D; Verma M; Brouwer M; Mishra R; Bhardwaj M
    BMJ Open; 2020 May; 10(5):e033706. PubMed ID: 32414819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study.
    Gebreweld FH; Kifle MM; Gebremicheal FE; Simel LL; Gezae MM; Ghebreyesus SS; Mengsteab YT; Wahd NG
    J Health Popul Nutr; 2018 Jan; 37(1):1. PubMed ID: 29304840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why did I stop? And why did I restart? Perspectives of women lost to follow-up in option B+ HIV care in Dar es Salaam, Tanzania.
    Sariah A; Rugemalila J; Protas J; Aris E; Siril H; Tarimo E; Urassa D
    BMC Public Health; 2019 Aug; 19(1):1172. PubMed ID: 31455306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TB treatment non-adherence in São Tomé and Príncipe.
    Bandeira S; da Trindade S; Raguenaud ME; Sousa B
    Public Health Action; 2022 Dec; 12(4):195-200. PubMed ID: 36561905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India.
    Zhou TJ; Lakshminarayanan S; Sarkar S; Knudsen S; Horsburgh CR; Muthaiah M; Kan CK; Salgame P; Ellner JJ; Roy G; Jenkins HE; Hochberg NS
    Am J Trop Med Hyg; 2020 Sep; 103(3):1050-1056. PubMed ID: 32618243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why people die of active tuberculosis in the era of effective chemotherapy in Southern Ethiopia: A qualitative study.
    Shegaze M; Boda B; Ayele G; Gebremeskel F; Tariku B; Gultie T
    J Clin Tuberc Other Mycobact Dis; 2022 Dec; 29():100338. PubMed ID: 36405995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment.
    Rodrigues MMS; Barreto-Duarte B; Vinhaes CL; Araújo-Pereira M; Fukutani ER; Bergamaschi KB; Kristki A; Cordeiro-Santos M; Rolla VC; Sterling TR; Queiroz ATL; Andrade BB
    BMC Public Health; 2024 May; 24(1):1385. PubMed ID: 38783264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.
    Jhaveri TA; Jhaveri D; Galivanche A; Lubeck-Schricker M; Voehler D; Chung M; Thekkur P; Chadha V; Nathavitharana R; Kumar AMV; Shewade HD; Powers K; Mayer KH; Haberer JE; Bain P; Pai M; Satyanarayana S; Subbaraman R
    PLoS Med; 2024 May; 21(5):e1004409. PubMed ID: 38805509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].
    Tatés-Ortega N; Álvarez J; López L; Mendoza-Ticona A; Alarcón-Arrascue E
    Rev Panam Salud Publica; 2019; 43():e91. PubMed ID: 31892925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study.
    Wohlleben J; Makhmudova M; Saidova F; Azamova S; Mergenthaler C; Verver S
    BMC Infect Dis; 2017 Aug; 17(1):543. PubMed ID: 28778187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.